TABLE A3.
Australia | Canada | England | France | Germany | Netherlands | New Zealand | Spain | Sweden | Switzerland | United States | |
---|---|---|---|---|---|---|---|---|---|---|---|
Year of data | 2012–2016 | 2016–2017 | 2014–2017 | 2016–2017 | 2016–2017 | 2016–2017 | 2016–2017 | 2015–2016 | 2015–2016 | 2015–2016 | 2016–2017 |
Country population | |||||||||||
Total | 23.5 million | 35.2 million (Canada 2016) | 55.3 million (in 2016) | 64.5 million | 82.2 million | 16.9 million | 4.7 million | 46.6 million | 9.9 million | 8.4 million | 323.1 million |
Population age 65+ | 3.5 million | 5.9 million (Canada 2016) | 9.9 million (in 2016) | 12.3 million | 16.8 million | 2.4 million | 733,272 | 8.3 million | 1.9 million | 1.5 million | 49.2 million |
Sample population (dataset) | |||||||||||
Representativeness of dataset | Regional data (New South Wales) | Regional data (Ontario Province) | National sample | 12 regions of France | National sample | National sample | Full national data | Regional data (Aragon, Spain) | Full national data | Full national data | National sample |
Total sample in dataset | 267,086 | 14.5 million | 7% of the UK population, representative in terms of age and sex | 43.1 million | 8.6 million | 30% market share | 4.7 million | 1.3 million | 9.9 million | 8.4 million | 6.4 million |
Population age 65+ in dataset | 123,625 | 2.5 million | 8.2 million | 2.5 million | 733,272 | 288,738 (21.73%) | 1.9 million | 1.5 million | 5.4 million |
Note: Specific full denominator was not able to be shared by data supplier in England and in the Netherlands. In Australia, the full sample of the 45 and up study cohort at baseline is n = 267,153 but for this research sample was 267,086.